Monitoring MRD in Multiple Myeloma in Serum by Mass Spectrometry

Clinical trial NCT07691034 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07691034
Sponsor: Odense University Hospital
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Multiple Myeloma Minimal Residual Disease

Start date: 2026-08-04
Primary completion: 2029-01-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.